Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Tyramide signal amplification during immunofluorescent staining enables the sensitive detection of phosphorylated RIPK3 and MLKL during ZBP1-induced necroptosis after HSV-1 infection.

Abstract

The kinase Receptor-interacting serine/threonine protein kinase 3 (RIPK3) and its substrate mixed lineage kinase domain-like (MLKL) are critical regulators of necroptosis, an inflammatory form of cell death with important antiviral functions. Autophosphorylation of RIPK3 induces phosphorylation and activation of the pore-forming executioner protein of necroptosis MLKL. Trafficking and oligomerization of phosphorylated MLKL at the cell membrane results in cell lysis, characteristic of necroptotic cell death. The nucleic acid sensor ZBP1 is activated by binding to left-handed Z-form double-stranded RNA (Z-RNA) after infection with RNA and DNA viruses. ZBP1 activation restricts virus infection by inducing regulated cell death, including necroptosis, of infected host cells. Immunofluorescence microscopy permits the visualization of different signaling steps downstream of ZBP1-mediated necroptosis on a per-cell basis. However, the sensitivity of standard fluorescence microscopy, using current commercially available phospho-specific antibodies against human RIPK3 and MLKL, precludes reproducible imaging of these markers. Here, we describe an optimized staining procedure for serine (S) phosphorylated RIPK3 (S227) and MLKL (S358) in human HT-29 cells infected with herpes simplex virus 1 (HSV-1). The inclusion of a tyramide signal amplification (TSA) step in the immunofluorescent staining protocol allows the specific detection of S227 phosphorylated RIPK3. Moreover, TSA greatly increases the sensitivity of the detection of S358 phosphorylated MLKL. Together, this method enables the visualization of these two critical signaling events during the induction of ZBP1-induced necroptosis.

Introduction

Receptor-interacting serine/threonine protein kinase 3 (RIPK3) and mixed lineage kinase domain-like (MLKL) are central regulators of necroptotic cell death1,2. Necroptosis is a lytic and inflammatory form of regulated cell death involved in antiviral immunity and autoinflammation. Necroptosis of virus-infected cells immediately shuts down virus replication. Cell lysis following necroptosis induction also releases damage-associated molecular patterns, which stimulate antiviral immunity3,4. Necroptosis is initiated by the activation of RIPK3 following RI....

Protocol

1. Preparation of biotinylated tyramide

  1. Prepare biotinylated tyramide starting from biotin-tyramide. To make a 10 mM stock solution, dissolve 3.6 mg of biotin-tyramide in 1 mL of DMSO. Store the dissolved product in aliquots at −20 °C to preserve the quality.

2. Maintaining HT-29 cells in culture

NOTE: ZBP1-expressing HT-29 were generated by transduction with a lentivector27 encodi.......

Representative Results

The immunofluorescent detection of MLKL phosphorylation and especially RIPK3 phosphorylation in human cells is technically challenging26. We here present an improved staining protocol for human p-RIPK3 (S227) and p-MLKL (S358) upon the activation of ZBP1. The protocol includes a TSA step to improve the detection limit and sensitivity of the fluorescent signals. To validate the method, a side-by-side comparison of the TSA-mediated immunofluorescence with standard indirect fluorescent staining of bo.......

Discussion

This immunofluorescent staining protocol describes the use of tyramide signal amplification (TSA) to increase the sensitivity for signaling events of the human necroptotic signaling pathway that are difficult to detect, including the phosphorylation of RIPK3 and MLKL26. The inclusion of a TSA step significantly improves the detection threshold of p-RIPK3 (S227) and p-MLKL (S358) and increases the sensitivity of p-MLKL (S358) straining. TSA revealed a p-RIPK3 (S227) signal already present in the mo.......

Acknowledgements

We would like to thank the VIB Bioimaging Core for training, support, and access to the instrument park. J.N. is supported by a PhD fellowship from the Research Foundation Flanders (FWO). Research in the J.M. group was supported by an Odysseus II Grant (G0H8618N), EOS INFLADIS (40007512), a junior research grant (G031022N) from the Research Foundation Flanders (FWO), a CRIG young investigator proof-of-concept grant, and by Ghent University. Research in the P.V. group was supported by EOS MODEL-IDI (30826052), EOS INFLADIS (40007512), FWO senior research grants (G.0C76.18N, G.0B71.18N, G.0B96.20N, G.0A9322N), Methusalem (BOF16/MET_V/007), iBOF20/IBF/039 ATLANTIS, ....

Materials

NameCompanyCatalog NumberComments
Antibodies
Anti-rabbit HRPAgilent Technologies BelgiumK4002Envision+ System-HRP Labelled Polymer anti-rabbit
Goat anti-mouse DyLight 633Thermofisher35513Secundary antibody
HSV-1 ICP0Santa Cruzsc-53070Mouse anti-ICP0(HSV-1) antibody
IAV-PR8 mouse serumIn house productionxxMouse anti-IAV-PR8 polyclonal antibody
pMLKLAbcamab187091Rabbit anti-MLKL-phospho S358 antibody
pRIPK3Abcamab209384Rabbit anti-RIPK3-phospho S227 antibody
Fluorophores
DAPIThermofisherD21490To visualise the nucleus of the cells
Streptavidin coupled to Alexa Fluor 568ThermofisherS11226To visulalise biotin molecules
Compounds
30% H2O2SigmaH1009Oxidising substrate, necessary for HRP activity
4% PFASANBIOAR1068To fix/crosslink the cells
Biotinyl-tyramideR&D Systems6241To amplify signal, HRP substrate
BV-6SelleckchemS7597BV6 IAP Inhibitor
      For cell culture: to detach the cells
      8.0 g/L NaCl
      0.4 g/L disodium salt of EDTA
EDTA 0.04%In house formulation1.1 g/L Na2HPO4
      0.2 g/L NaH2PO4
      0.2 g/L KCl
      0.2 g/L Glucose
Fetal Bovine serumTICOFBS EU XXXFor cell culture, maintaining cell culture; lot number: 90439
GSK'840AobiousAOB0917RIPK3 kinase inhibitor
L-GlutamineSigma-AldrichG7513For cell culture, maintaining cell culture
MAXblockActive Motif15252Blocking solution
PBSGibco10444402
Sodium pyruvateSigma-AldrichS8636For cell culture, maintaining cell culture
TNF-αIn house production-Signaling molecule, able to trigger cell death in combination with BV6 and zVAD
Triton X-100Sigma AldrichT8787-50MLTo permeabilise the cells
Trypan blueMerck11732For cell counting, used as live/dead marker at 0,1%
TrypsineSigma-AldrichT4424For cell culture: to detach the cells
zVADBachemBACE4026865.0005Z-Val-Ala-DL-Asp-fluoromethylketone
Material
µ-Slide 8 well high glass bottomiBidi80807To culture the cells
Cotton Preping Balls-size mediumElectron Microscopy Sciences71001-10To clean the objectives
Immersol 518 F / 30 °CZEISS444970-9000-000To visualise the sample at high magnifications
Lens CleanerZEISS000000-0105-200To clean the objectives
LSM880 Fast Airyscan confocal microscopeTo visualise the sample
Software
ExcelOfficexxTo process the data
Prism 9GraphpadxxTo analyse the data- statistical testing and graph generation
Volocity 6.3VolocityxxTo perform quantifications
Zen blackZEISSxxTo aquire and process images
Zen blueZEISSxxTo visualise images
Viruses
HSV-1 (mutRHIM) F strainproduced by  Dr. Jiahuai Hanin house replicationHSV-1 as a trigger for necroptosis; RHIM core domain of UL39/ICP6 is mutated (VQCG>AAAA)
HSV-1 (WT) F strainProduced by Dr. Jiahuai Hanin house replicationHSV-1 (WT) as a negative control for necroptosis induction (ICP6 inhibition)
IAV PR8in house stockin house replicationIAV as a trigger for necroptosis

References

  1. Meng, Y., Sandow, J. J., Czabotar, P. E., Murphy, J. M. The regulation of necroptosis by post-translational modifications. Cell Death & Differentiation. 28 (3), 861-883 (2021).
  2. Petrie, E. J., Czabotar, P. E., Murphy, J. M. The str....

Explore More Articles

Tyramide Signal AmplificationImmunofluorescent StainingZBP1PhosphorylationRIPK3MLKLNecroptosisHSV 1Human CellsMicroscopyCell CultureFixationPermeabilizationAntibody Staining

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved